Pete Flint’s Post

A lean start-up is a scientific approach in creating and managing start-up companies focused on faster product release. Read the post to learn more & Share your thoughts in the comments. Follow us to see more content. #sixsigmatraining #businessexcellence #leansixsigma #leanstartup #leancanvas

🚀 Biotech CFOs: Your Next Breakthrough Isn't in the Lab Our latest case study reveals how one biotech startup achieved liftoff: 🔬 304% ROI over 3 years 💉 $832,500 saved (hello, new equipment!) 🧬 19-month runway extension How? By revolutionizing their finance operations. Want to fuel your next discovery? Check out the full case study below Link - https://lnkd.in/gmbBBBAB #BiotechFinance #StartupGrowth #CFOStrategy

Tips, insights, and a full-replay of our latest webinar with Qualio, "Securing investment in life sciences: insights and tactics." Nicolle Cannon, Founder & CEO, Cannon Quality Group, LLC and Stephen Meserve, Senior Director of Product Marketing walk us through how to secure life sciences investment, and share startup funding tips and insights from their latest webinar. https://hubs.la/Q02lKM2M0 #medtech #medtechfunding

Ventures w/ Jeffrey Low, MD @ Novo Holdings, Growth Investments How are novel AI technologies and the principles of TechBio transforming traditional approaches to life sciences investment and drug discovery? In our latest episode of BIOS Ventures, Jeffrey Low of Novo Holdings shares unparalleled insights into leveraging permanent capital for long-term innovation, and the critical role diversity plays in enriching scientific breakthroughs. We delve into specific examples where these strategies have accelerated the path from lab bench to market, setting new standards for the industry. How do you see AI and TechBio influencing future investment decisions in your field? Tune in below to hear Jeffrey Low's insights on the future of life sciences investing & how Novo is leading the charge in the next advancements of the industry. Watch it here: https://buff.ly/3OVVKko #LifeSciences #AIInnovation #TechBio #StrategicInvestment

What will investors typically ask for or expect during science-tech due diligence? (Part 4/8) Part IV of our series on what investors typically ask or expect during science-tech due diligence focuses on the elements of functional performance (breakthrough assessment), and ease of use. For an overview of the previous elements, download the free guide via the link in the comments. → Breakthrough and Functional Performance To create outlier returns, your solution must offer substantial improvements over existing technologies, whether in cost, efficiency, or sustainability. Investors will evaluate how differentiated your technology is and assess the risks associated with your solution’s ability to meet or exceed performance expectations compared to incumbents. → Ease of Use (Complexity) Investors will also assess the risks associated with industry adoption, including operational switching costs and how easily users can implement the technology. Make sure not to underestimate the real costs of switching: perceived risks of using a new solution from a startup, and any emotional attachment users may have to current methods do play a part. Next up: Part V on defensibility and intellectual property (IP). #techduediligence #deeptech #fundraising #vc #climatetech

Great news! Our collaborative study on Public Sector Body Spinouts, co-authored with Tomas Coates Ulrichsen, at Policy Evidence Unit for University Commercialisation & Innovation (UCI), at the Institute for Manufacturing (IfM), University of Cambridge, and Elaine Eggington, Luke Kinsman, Michael Lasek, at Wellspring (IP Pragmatics Ltd) is live with the Government Office for Technology Transfer! 💡 What we explored: ⚫ Key trends in the production and performance of public sector body spinouts ⚫ Spinout models, deal terms and rewards for public sector innovators ⚫ Support for spinout companies ➡️ Link to the study: https://lnkd.in/etp56uda ⭕ Key findings below 👇 #innovation #commercialisation #spinouts #publicsector #GOTT

With innovation occurring every day, you’d think we – as a country – would have nailed down innovation as a science, right? The truth is there is no textbook answer that ensures innovation is a scalable, repeatable process. Brazos Innovation Partners (BIP) works diligently to bridge the gaps that exist between university researchers, venture capitalists, and industry through strategy, resources, and network. BIP is pioneering a new era of successful innovation that functions as a science and not the outcome of happy accidents and serendipity. #innovation #venturecapital #research #techindustry

Over the past few years, the pace of innovation seems to have increased dramatically. New products are seemingly launched and talked about (at least on LinkedIn) on a daily basis. Many of these innovations have a definite “wow” factor. One can’t, however, sometimes seem to shake off the feeling that these innovations are geared towards consumers who already are in a reasonable place in life. These consumers, perhaps, have more disposable incomes and it makes sense to gear products towards their needs. On the one hand, that does seem like a reasonable business strategy. On the other hand, is that sustainable for society as a whole? At Bessel, we applaud and are mesmerized by all forms of innovation, while aiming to deliver solutions that speak to an “average” household. There are challenges faced by many such households for which science and technology can offer affordable solutions. At Bessel, our aim is to deliver such solutions. Learn more about us: https://besselplumbing.com

Failing Fast Can Help You Succeed! How many projects are researched before understanding which one should be brought to commercialization? Failing fast can help many organizations get to market quicker with a successful product. Stephen M. Perry recently partnered with LaunchBio Inc. to interview Rick Bente and Marcelo Tellez Anderson. This discussion serves as a case study and draws upon past experiences related to bringing products to market, specifically focusing on the utilization of our Hyper-Virtual partnership model. Highlighting areas such as: ☑ Selecting the right partner will help you de-risk and successfully map out expertise through the product lifecycle. ☑ Accelerating budget management to scale up or down as needed. ☑ Understanding the value of time management and opportunity cost. ☑ The value of owning your data. Listen to this insightful webinar here: https://lnkd.in/eEpdkNrM Part 2 of this three-part series starts today. Register now: https://lnkd.in/eMhq4xU5 Dan Kagan & Evan Edwards join Stephen at 1:00pm. #DeviceDesign #Regulatory #MedTech #LifeScience